Ultralife Corporation (ULBI)
| Market Cap | 93.31M -16.3% |
| Revenue (ttm) | 187.24M +4.7% |
| Net Income | -6.55M |
| EPS | -0.39 |
| Shares Out | 16.66M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,149 |
| Open | 5.67 |
| Previous Close | 5.65 |
| Day's Range | 5.59 - 5.77 |
| 52-Week Range | 4.90 - 8.25 |
| Beta | 0.83 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About ULBI
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commerci... [Read more]
Financial Performance
Financial StatementsNews
Ultralife Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue of $47.9M, record backlog nearing $130M, and strong gross margin gains driven by new product launches and operational improvements. Segment growth was led by Communications Systems, while Battery & Energy Products benefited from margin initiatives and vertical integration.
Ultralife Earnings release: Q2 2026
Ultralife released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Ultralife Quarterly report: Q2 2026
Ultralife has published its Q2 2026 quarterly earnings report on August 7, 2026.
Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 mi...
Ultralife Corporation to Report Second Quarter Results on August 7, 2026
NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, Augus...
Ultralife Proxy statement: Proxy filing
Ultralife filed a proxy statement on June 2, 2026, providing details for shareholder voting and corporate governance matters.
Ultralife Proxy statement: Proxy filing
Ultralife filed a proxy statement on June 2, 2026, providing details for shareholder voting and corporate governance matters.
Ultralife Earnings Call Transcript: Q1 2026
Q1 2026 saw revenue and gross margin declines due to shipment delays, plant shutdowns, and one-time costs, but a record backlog and new product launches position the business for future growth. Focus remains on operational improvements and vertical integration.
Ultralife Earnings release: Q1 2026
Ultralife released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Ultralife Quarterly report: Q1 2026
Ultralife has published its Q1 2026 quarterly earnings report on May 8, 2026.
Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2026 as follows:
Ultralife Corporation to Report First Quarter Results on May 8, 2026
NEWARK, N.Y., May 01, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2026 before the market opens on Friday, May 8, ...
Ultralife Earnings Call Transcript: Q4 2025
Q4 2025 revenue rose 10.6% year-over-year, but a one-time impairment led to a net loss. Backlog reached $110 million, and operational improvements and new product launches position the company for growth and margin expansion in 2026.
Ultralife Annual report: Q4 2025
Ultralife has published its Q4 2025 annual report on March 10, 2026.
Ultralife Earnings release: Q4 2025
Ultralife released its Q4 2025 earnings on March 10, 2026, summarizing the period's financial results.
Ultralife reports Q4 EPS (45c) vs 1c last year
Reports Q4 revenue $48.5M vs $43.852M last year. “During the fourth quarter we took a number of decisive actions to remove structural and manufacturing inefficiencies from our global operations. For…
Ultralife Corporation Reports Fourth Quarter Results
NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows:
Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026
NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday,...
Ultralife Earnings Call Transcript: Q3 2025
Q3 2025 saw revenue growth to $43.4M but a net loss of $0.07 per share due to one-time costs and supply chain issues. Strategic actions included facility consolidation, new product launches, and a completed Electric Chem integration, positioning for improved margins and growth in 2026.
Ultralife Earnings release: Q3 2025
Ultralife released its Q3 2025 earnings on November 18, 2025, summarizing the period's financial results.
Ultralife Quarterly report: Q3 2025
Ultralife has published its Q3 2025 quarterly earnings report on November 18, 2025.
Ultralife reports Q3 EPS (7c) vs 2c last year
Reports Q3 revenue $43.4M vs $35.7M last year. “Although revenue grew 2.5% organically and 21.5% including the Electrochem acquisition for the third quarter, supply chain issues caused manufacturing i...
Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results:
Ultralife Corporation to Report Third Quarter Results on November 18, 2025
NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, N...
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Comm...